scholarly article | Q13442814 |
P356 | DOI | 10.1177/2047487317706585 |
P8608 | Fatcat ID | release_t535fn7kajgddb5bynytw3frfu |
P698 | PubMed publication ID | 28429955 |
P50 | author | Mikko T Nieminen | Q43269029 |
Aki S Havulinna | Q57560665 | ||
Stefan Blankenberg | Q28039327 | ||
Veikko Salomaa | Q28050067 | ||
Tanja Zeller | Q29840607 | ||
P2093 | author name string | Timo Sorsa | |
Taina Tervahartiala | |||
Pirkko J Pussinen | |||
Immi Kormi | |||
P2860 | cites work | Serum matrix metalloproteinase-8 concentrations are associated with cardiovascular outcome in men. | Q43769669 |
Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation | Q44448828 | ||
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study | Q46736337 | ||
Unstable carotid plaques exhibit raised matrix metalloproteinase-8 activity | Q47266111 | ||
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study | Q47406734 | ||
Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study | Q47960038 | ||
Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction | Q48162839 | ||
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. | Q48711796 | ||
Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases. | Q52664719 | ||
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction. | Q53664698 | ||
Practical implications of novel serum ELISA-assay for matrix metalloproteinase-8 in acute cardiac diagnostics | Q57315634 | ||
Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: results from the MONICA/KORA Augsburg study | Q57414500 | ||
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data | Q28742740 | ||
Inflammation in atherosclerosis | Q29547428 | ||
Heart disease and stroke statistics--2012 update: a report from the American Heart Association | Q29547909 | ||
General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Q29614189 | ||
Myeloperoxidase and its contributory role in inflammatory vascular disease. | Q30352941 | ||
The validation of the Finnish Hospital Discharge Register and Causes of Death Register data on stroke diagnoses | Q31115680 | ||
The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity | Q33786342 | ||
Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography | Q34103514 | ||
Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality | Q34222299 | ||
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
Genetic risk prediction and a 2-stage risk screening strategy for coronary heart disease | Q34411343 | ||
Endotoxemia is associated with an increased risk of incident diabetes | Q34507178 | ||
Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction | Q34963719 | ||
Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity | Q35536038 | ||
Tissue Inhibitor of Metalloproteinase-1: Actions beyond Matrix Metalloproteinase Inhibition. | Q36526033 | ||
Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. | Q36580334 | ||
Do metalloproteinases destabilize vulnerable atherosclerotic plaques? | Q36589031 | ||
Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. | Q36805538 | ||
C-reactive protein, fibrinogen, and cardiovascular disease prediction | Q37021409 | ||
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis | Q37963722 | ||
Onset of mucosal, dermal, and general symptoms in relation to biomarkers and exposures in the dwelling: a cohort study from 1992 to 2002. | Q38434905 | ||
Apolipoprotein B improves risk assessment of future coronary heart disease in the Framingham Heart Study beyond LDL-C and non-HDL-C. | Q39045940 | ||
Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study | Q40196845 | ||
Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice | Q40224260 | ||
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study. | Q40380481 | ||
Depression and Its Comorbid Conditions More Serious in Women than in Men in the United States. | Q41624031 | ||
Geographic patterns of incidence of ischemic stroke and acute myocardial infarction in Finland during 1991-2003. | Q42645598 | ||
Thirty-five-year trends in cardiovascular risk factors in Finland | Q43230334 | ||
P433 | issue | 11 | |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 1136-1144 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | European Journal of Preventive Cardiology | Q2493290 |
P1476 | title | Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident cardiovascular disease events and all-cause mortality in a population-based cohort. | |
P478 | volume | 24 |
Q64071126 | Association of Circulating Tissue Inhibitor of Metalloproteinases-1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease |
Q57156814 | Diagnosis of Newly Delivered Mothers for Periodontitis with a Novel Oral-Rinse aMMP-8 Point-of-Care Test in a Rural Malawian Population |
Q97545917 | Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 - secondary analysis of a randomized controlled trial |
Search more.